Psykedeliske stoffer i behandling av angst, depresjon og avhengighet
Tidsskrift for Den norske legeforening – January 01, 2018
Source: OpenAlex
Summary
Psychedelics, complex alkaloids from chemical synthesis, show compelling promise for mental health treatment. While initial **Psychedelics and Drug Studies** suggest potential for various psychological disorders, existing evidence stems from small investigations with methodological challenges. Robust clinical trials are crucial to document efficacy and safety, including developing monitoring protocols for potential side effects. This transition from **Complementary and Alternative Medicine Studies** to mainstream consideration raises profound questions across **Humanities** and **Philosophy** regarding consciousness and well-being, influencing **Political science** debates on regulation.
Abstract
Psykedeliske stoffer i behandling av flere psykiske lidelser har vist lovende resultater, men studiene er små og har metodologiske utfordringer. Det er behov for systematiske kliniske studier for å skaffe solid dokumentasjon for effekt og etablere rutiner for overvåkning av mulige bivirkninger.